AntiArrythmtic Drug

Download as pdf or txt
Download as pdf or txt
You are on page 1of 17

Cardiac arrhythmia

Cardiac arrhythmia is the condition in which


the heart’s normal rhythm (75beats/minute)
is disrupted.
The Conduction System

Bundle of His

Purkinje fibre
The Conduction System

Electrical impulses from your heart muscle (the myocardium) cause


your heart to beat (contract). This electrical signal begins in the
sinoatrial (SA) node, located at the top of the right atrium. The SA
node is sometimes called the heart's "natural pacemaker." When an
electrical impulse is released from this natural pacemaker, it causes
the atria to contract. The signal then passes through the
atrioventricular (AV) node. The AV node checks the signal and sends it
through the muscle fibers of the ventricles, causing them to contract.
The SA node sends electrical impulses at a certain rate, but your heart
rate may still change depending on physical demands, stress, or
hormonal factors.
ARRHYTHMIAS

DEFINITION
Abnormal heart rhythm that is abnormalities in impulse
formation and conduction in the myocardium.
It is the disorder in rate and rhythm of cardiac contraction
due to myocardial damage is called cardiac arrhythmia.

Types.

Bradycardia
Heart rate < 60 bpm; impulse originates in SA node

Tachycardia
Heart rate >100-160 bpm; impulse does not originate in SA
node
Signs & symptoms

- irregular heartbeat
- Palpitations
- Chest discomfort
- Shortness of breath
- Dizziness
- Weakness
- Nausea

Fever
fatigue
Aetiology / risk factors
• Coronary artery disease
• High blood pressure
• Congenital heart disease
• Thyroid problems
• Obesity
• Uncontrolled diabetes
• Electrolyte imbalance
• Air pollution
PREVALENCE OF CARDIAC ARRHYTHMIAS

• Cardiac arrhythmias are common.


• Statistics from the centers for Disease control and prevention
(CDC) has estimated sudden cardiac death rates at more than
600,000 per year worldwide.
• Up to 50% of patients have sudden death as the first
manifestation of cardiac disease .
• Cardiac arrhythmias are common in the elderly and are often
asymptomatic.
• Approximately 2.2 million individuals in US have CA and
approximate 4.5million individuals in European union have CA.
Management/Treatment
• Anticoagulant medication to reduce the risk
of blood clots and stroke.
• Cardiac ablation/Surgery
• Antiarrhythmic drugs medications.

PREVENTION
• Treat or when possible eliminate risk factors
• Making healthy lifestyle choices
• Exercising regularly
• Eating a healthy, low fat diet with plenty of vegetables,
fruits for healthy heart
• Maintaining a healthy weight
• Avoid or stop smoking
• Avoiding unnecessary stress such as anger, anxiety or fear
• Having regular physical exams and reporting unusual
symptoms to physician.
• Treat underlying medical condition that may contribute to
arrhythmia.
Antiarrhythmic drugs
Class I (Na+ channel blocker)
• Quinidine
• Lidocaine
• Procainamide
The antiarrhythmic drugs can
• Propafenone
Class II (β-adrenoceptor blockers) modify impulse generation
• Propranolol and conduction
• Metoprolol
• Pindolol
Class III (K+ channel blockers)
• Amiodarone
• Sotalol
Class IV (Ca2+ channel blockers)
• Verapamil
• Diltiazem
Other anti-arrhythmic drugs
• Adenosin
• Digoxin
Cardiac Electro-Physiology
• Phase 0: Rapid depolarisation of the cell membrane and it is associated with
the inflow of the Na+ ions.

• Phase 1: A short initial phase of rapid repolarisation due to activation of a


Cl- current (inflow). K+ channel rapidly open and close causing a transient outward
current.
• Phase 2: Action potential plateau. A period of more gradual repolarisation in which
there is a movement of Ca2+ ion into the cell.
• Phase 3: Final repolarisation. A second period of rapid repolarisaion during which
K+ move out of the cell.
• Phase 4: A fully repolarised state during which K+ channel opens. K+ move into
and Na+ out of the cell again to enable the next cycle to begin.

1 2
3
0
4 4

Anti-arrhythmic drugs act at different points in cardiac action potential cycle.


M/A of Quinidine

Quinidine

Membrane stabilizing action


Prolongs refractory period
(blocks the activation of Na+
channel)

Suppress of SA node Prevent re-entry rhythm


Prevent ectopic beats
AV conduction block

↓ Automaticity
↓ Excitability and conductivity

Anti-arrhythmic effect
Quinidine

Pharmacological effect Adverse Effect


On Cardiac tissue:
↓ Automaticity
CVS:
↓ Conductivity
• Heart block
Prolong refractory period • Sinus arrest
• Myocardial depression
Other action: • Q-T prolongation
Anti-malarial effect CNS: Headache, Blurred vision
Anti-pyretic effect GIT: Nausea, vomiting, dirrhoea.
Vasodilation (hypotension) Allergic: Rash, fever.

Therapeutic uses
• Arrhythmia
• Malaria
• Pyrexia (fever)
M/A of Lidocain

Lidocaine

Membrane stabilizing action


Shorten refractory period
(blocks the activation of Na+
Shorten action potential
channel)

Suppress of SA node Make the rhythm uniform


Prevent ectopic beats

Anti-arrhythmic effect
M/A of Lidocain

Therapeutic uses

• Ventricular arrhythmia
• Local anaesthesia

Adverse effects

• Bradycardia
• Hypotension
• Dizzinesws
• Blurred vision
• Confusion
• Convulsion
M/A of Propranolol

Direct membrane stabilizing effect

↓ Automaticity

↓ Conduction velocity

↑ Refractory period

Anti-arrhythmia
Propranolol

Therapeutic uses

• Anti-arrhythmia
• Hypertension
• Angina

You might also like